Genmab — August 2016
-
@JohnW. Hvis man investerer langsigtet i Genmab burde man være ligeglad med sektor rotation og Domenick Beskos...Hvis man I det hele taget lader sig kue af st
ore udsving, så investere man ikke i biotek. ps hvad er din investeringsstrategi du virker alt for bekymret til at være biotekaktionær? -
Er der nogen, der ved, om Dara er med inde over denne historie ? http://www.bt.dk/sundhed/ny-kraeftbehandling-stormer-frem-dorte-fik-doedsdom-nu-er-hun-kraeftfri
-
@Mayflower. Antistoffer kan godt kommer over BBB, om end bioavailability er lav. Der er mængder af antistoffer i kliniske studier mod alzheimer som gives IV.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind